Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
TriMetis Life Sciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
TriMetis Life Sciences

TriMetis Life Sciences

Seed

TriMetis: Accelerating tissue-based businesses with quality biospecimens, innovative tech, and research expertise.

HQ
Memphis, TN, US
Founded
2011
Overview
Compare
Fundraising
Employees

TriMetis Life Sciences is dedicated to accelerating tissue-based businesses by providing access to high-quality biospecimens, innovative quality control technology, and research expertise. The company focuses on supporting the biotech and pharmaceutical industries, enhancing their research and development capabilities.

TriMetis has made significant strides in the life sciences sector, contributing to advancements in tissue-based research. Their impact is evident in the improved efficiency and accuracy of biotech and pharmaceutical research, driven by their commitment to quality and innovation.

TriMetis Life Sciences - Similar Companies

Transomic Technologies logo

Transomic Technologies

iSpecimen logo

iSpecimen

ispecimen.com

LifeX logo

LifeX

lifex-labs.com

Mitogenetics logo

Mitogenetics

mitogenetics.com

BioAnalytics logo

BioAnalytics

InVivo Biosystems logo

InVivo Biosystems

Vivebio logo

Vivebio

Triplebar logo

Triplebar

triplebar.com

BiomedInnovations logo

BiomedInnovations

Phenomix Sciences logo

Phenomix Sciences

Fortis Biosciences logo

Fortis Biosciences

BioAccel logo

BioAccel

Regenemed logo

Regenemed

regenemed.com

AnaBios logo

AnaBios

anabios.com

Conversant Bio logo

Conversant Bio

TriMetis Life Sciences - Quick Facts

Who are TriMetis Life Sciences' competitors?

Companies similar to TriMetis Life Sciences include Transomic Technologies, iSpecimen, LifeX and Mitogenetics.

When was TriMetis Life Sciences founded?

TriMetis Life Sciences was founded in 2011.

Where is TriMetis Life Sciences' headquarters located?

TriMetis Life Sciences' headquarters is located in Memphis, TN, US.

When was TriMetis Life Sciences' last funding round?

TriMetis Life Sciences' most recent funding round was for $250k (USD) in June 2014.

How much has TriMetis Life Sciences raised to-date?

As of Jun 23, 2014, TriMetis Life Sciences has raised a total of $250k (USD).

How many employees does TriMetis Life Sciences have?

TriMetis Life Sciences has 8 employees as of Feb 4, 2024.

TriMetis Life Sciences - Classification

Industry
  • Professional Service Companies
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Biospecimens
  • Research
Tags
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
ISIC
  • 7320Market research and public opinion polling
Show 10 more industry codes
NAICS
  • 513200Software Publishers
  • 541910Marketing Research and Public Opinion Polling
  • 510000Information
  • 513000Publishing Industries
  • 541900Other Professional, Scientific, and Technical Services
  • 513210Software Publishers
SIC
  • 8732Commercial Economic, Sociological, And Educational Research
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software